• Exchange: EN Amsterdam
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharming Group NV

+ Add to Watchlist

PHARM:NA

0.5230 EUR 0.0050 0.95%

As of 11:35:00 ET on 07/10/2014.

Snapshot for Pharming Group NV (PHARM)

Open: 0.5290 Day's Range: 0.5080 - 0.5370 Volume: 12,365,477
Previous Close: 0.5280 52wk Range: 0.1110 - 0.7260 1-Yr Rtn: +258.22%

Stock Chart for PHARM

No chart data available.
  • PHARM:NA 0.5230
  • 1D
  • 1M
  • 1Y
0.5280
Interactive PHARM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHARM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. AEX -
Earnings Per Share (EUR) (ttm) -0.0790
Est. EPS (EUR) (12/2014) -0.0030
Est. PEG Ratio -
Market Cap (M EUR) 212.00
Shares Outstanding (M) 405.35
30 Day Average Volume 12,749,430
Price/Book (mrq) -
Price/Sale (ttm) 0.5873
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHARM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for PHARM

Pharming Group NV is a biopharmaceutical company involved with the development, production and commercialization of human therapeutic proteins to be used in highly innovative therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage, and surgical/traumatic bleeding.

Sijmen De VriesChief Executive OfficerBruno M L GiannettiChief Operating Officer
More Company Profile & Key Executives for PHARM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil